Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cysteamine (cystagon) (1 trial)
npi-001 (2 trials)
Retinitis Pigmentosa (Phase 2)
Syndrome (Phase 2)
Usher Syndromes (Phase 2)
Trials (2 total)
Trial APIs (2 total)